Kistler-Tiffany Companies’s Teva Pharmaceuticals TEVA Stock Holding History

Kistler-Tiffany Companies’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$29K	Hold	3,857	–	–	﹤0.01%	566
2023 Q1	$34.1K	Hold	3,857	–	–	0.01%	474
2022 Q4	$35.2K	Sell	3,857 -126	-3%	-$1.1K	0.01%	459
2022 Q3	$32K	Sell	3,983 -156	-4%	-$1.38K	0.01%	436
2022 Q2	$31K	Hold	4,139	–	–	0.01%	440
2022 Q1	$39K	Hold	4,139	–	–	0.01%	423
2021 Q4	$33K	Buy	4,139 +3,738	+932%	+$33.7K	0.01%	424
2021 Q3	$4K	Buy	401 +126	+46%	+$1.18K	﹤0.01%	650
2021 Q2	$3K	Hold	275	–	–	﹤0.01%	643
2021 Q1	$3K	Hold	275	–	–	﹤0.01%	598
2020 Q4	$3K	Hold	275	–	–	﹤0.01%	580
2020 Q3	$2K	Hold	275	–	–	﹤0.01%	594
2020 Q2	$3K	Sell	275 -300	-52%	-$3.39K	﹤0.01%	544
2020 Q1	$6K	Hold	575	–	–	﹤0.01%	490
2019 Q4	$6K	Hold	575	–	–	﹤0.01%	498
2019 Q3	$4K	Sell	575 -875	-60%	-$6.7K	﹤0.01%	534
2019 Q2	$13K	Hold	1,450	–	–	﹤0.01%	414
2019 Q1	$23K	Hold	1,450	–	–	0.01%	331
2018 Q4	$22K	Hold	1,450	–	–	0.01%	313
2018 Q3	$31K	Hold	1,450	–	–	0.01%	295
2018 Q2	$35K	Hold	1,450	–	–	0.02%	287
2018 Q1	$25K	Hold	1,450	–	–	0.01%	344
2017 Q4	$27K	Sell	1,450 -2,524	-64%	-$38K	0.01%	340
2017 Q3	$70K	Buy	3,974 +301	+8%	+$6.77K	0.03%	236
2017 Q2	$122K	Buy	3,673 +1,571	+75%	+$48.6K	0.06%	174
2017 Q1	$67K	Sell	2,102 -188	-8%	-$6.42K	0.03%	224
2016 Q4	$83K	Sell	2,290 -147	-6%	-$5.87K	0.04%	206
2016 Q3	$112K	Buy	2,437 +302	+14%	+$15.8K	0.06%	177
2016 Q2	$107K	Buy	2,135 +64	+3%	+$3.41K	0.05%	178
2016 Q1	$111K	Buy	2,071 +2	+0.1%	+$117	0.06%	167
2015 Q4	$175K	Sell	2,069 -298	-13%	-$18.4K	0.1%	132
2015 Q3	$134K	Buy	2,367 +1	+0%	+$65	0.08%	159
2015 Q2	$140K	Buy	2,366 +2	+0.1%	+$123	0.08%	156
2015 Q1	$147K	Buy	2,364 +1	+0%	+$58	0.09%	134
2014 Q4	$136K	Buy	2,363 +1	+0%	+$56	0.09%	138
2014 Q3	$127K	Hold	2,362	–	–	0.08%	151
2014 Q2	$124K	Buy	2,362 +100	+4%	+$5.11K	0.09%	148
2014 Q1	$120K	Hold	2,262	–	–	0.09%	142
2013 Q4	$91K	Sell	2,262 -184	-8%	-$7.25K	0.07%	173
2013 Q3	$92K	Hold	2,446	–	–	0.07%	165
2013 Q2	$96K	Buy	+2,446	New	+$95.3K	0.08%	151

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kistler-Tiffany Companies's TEVA Position: Q2 2023 in Review

Kistler-Tiffany Companies held its Teva Pharmaceuticals (TEVA) position steady in Q2 2023 at 3,857 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #566.

Kistler-Tiffany Companies first reported a position in TEVA in Q2 2013 and has held it in 41 quarters since. The position peaked at $175K in Q4 2015. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

Kistler-Tiffany Companies held 3,857 shares of Teva Pharmaceuticals worth $29K as of Q2 2023.
Kistler-Tiffany Companies left its Teva Pharmaceuticals share count unchanged in Q2 2023.
Teva Pharmaceuticals made up ﹤0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #566 holding.
Kistler-Tiffany Companies first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 41 quarters since.
Kistler-Tiffany Companies's Teva Pharmaceuticals position peaked at $175K in Q4 2015.
428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.